Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

RUBY

Rubius Therapeutics (RUBY)

Rubius Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RUBY
일자시간출처헤드라인심볼기업
2023/04/1022:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
2023/03/0921:33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RUBYRubius Therapeutics Inc
2023/03/0401:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
2023/03/0222:43Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2722:23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2721:37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2720:52Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2720:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2720:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2220:46Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/2220:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/1002:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
2023/02/0706:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2023/01/2021:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
2022/12/2207:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2022/12/1506:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2022/12/1306:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2022/11/0305:01GlobeNewswire Inc.Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership ChangesNASDAQ:RUBYRubius Therapeutics Inc
2022/10/1405:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2022/09/1921:00GlobeNewswire Inc.Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics ConferenceNASDAQ:RUBYRubius Therapeutics Inc
2022/09/1613:20TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Rubius Therapeutics (RUBY) and Connect Biopharma Holdings (CNTB)NASDAQ:RUBYRubius Therapeutics Inc
2022/09/1320:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2022/09/1320:00GlobeNewswire Inc.Rubius Therapeutics Announces Strategic UpdateNASDAQ:RUBYRubius Therapeutics Inc
2022/09/1305:30GlobeNewswire Inc.Rubius Therapeutics to Provide Strategic UpdateNASDAQ:RUBYRubius Therapeutics Inc
2022/09/1001:40TipRanksAnalysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Palatin Technologies (PTN) and Rubius Therapeutics (RUBY)NASDAQ:RUBYRubius Therapeutics Inc
2022/08/1306:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
2022/08/1304:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RUBYRubius Therapeutics Inc
2022/08/1001:35TipRanksSVB Securities Keeps Their Hold Rating on Rubius Therapeutics (RUBY)NASDAQ:RUBYRubius Therapeutics Inc
2022/08/0921:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RUBYRubius Therapeutics Inc
2022/08/0921:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
 검색 관련기사 보기:NASDAQ:RUBY